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Propionibacterium acnes induction of IL-1 cytokines through the NLRP3 (NLR, nucleotide oligomerization
domain-like receptor) inﬂammasome was recently highlighted as a dominant etiological factor for acne vulgaris.
Therefore, therapeutics targeting both the stimulus and the cascade would be ideal. Nitric oxide (NO), a potent
biological messenger, has documented broad-spectrum antimicrobial and immunomodulatory properties. To
harness these characteristics to target acne, we used an established nanotechnology capable of generating/
releasing NO over time (NO-np). P. acnes was found to be highly sensitive to all concentrations of NO-np tested,
although human keratinocyte, monocyte, and embryonic zebra ﬁsh assays revealed no cytotoxicity. NO-np
signiﬁcantly suppressed IL-1β, tumor necrosis factor-α (TNF-α), IL-8, and IL-6 from human monocytes, and IL-8
and IL-6 from human keratinocytes, respectively. Importantly, silencing of NLRP3 expression by small interfering
RNA did not limit NO-np inhibition of IL-1 β secretion from monocytes, and neither TNF-α nor IL-6 secretion, nor
inhibition by NO-np was found to be dependent on this pathway. The observed mechanism by which NO-np
impacts IL-1β secretion was through inhibition of caspase-1 and IL-1β gene expression. Together, these data
suggest that NO-np can effectively prevent P. acnes-induced inﬂammation by both clearing the organism and
inhibiting microbial stimulation of the innate immune response.
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INTRODUCTION
Acne’s multifactorial etiology, resulting from a mix of
hormone-induced elevations in sebum production, abnormal
follicular epithelial desquamation and proliferation, hyperco-
lonization of P. acnes, and host inﬂammatory reactions,
makes treatment often times challenging (Zouboulis et al.,
2005; Castro and Ferreira, 2008). This challenge has fueled
the development of innovative delivery platforms that
improve delivery and efﬁcacy of established and
investigative agents. Various particulate delivery platforms
have been evaluated for the use in acne, including liposomes
and nanoparticles (nps). These carriers have the advantage of
gradual release (Manconi et al., 2002), minimizing irritancy
(Manconi et al., 2002), follicular targeting/enhanced follicular
penetration (Jung et al., 2006), and cutaneous retention of the
active ingredient (Manconi et al., 2006). More importantly,
the unique properties conferred by the vehicles existing at the
nanoscale are allowing for the investigation of new
therapeutics, which in their bulk form can not be delivered
topically because of stability and solubility issues, including
lauric acid (Nakatsuji et al., 2009) and chitosan (Friedman
et al., 2013).
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Along this vein, np platforms can be a vehicle through
which unstable therapeutically relevant agents are harnessed.
Nitric oxide (NO) represents one such molecule—a diatomic,
lipophilic gaseous molecule with functions described ranging
from vascular modulation to cell cycle regulation, pro- and
anti-inﬂammatory properties, and microbicidal/static activity
(Friedman and Friedman, 2009). The simplicity of NO mixed
with its biological potency and complexity makes it an
extremely promising pharmacological agent, but utilization
has been limited because of the lack of effective and safe
delivery systems. We previously reported on a hybrid
hydrogel-sugar-based nanoparticulate system (np) capable of
generating physiologic concentrations of NO over time. On
exposure to an aqueous environment, the hydrogen bonding
network that comprises the np matrix loosens, allowing release
of the NO (Friedman et al., 2008; Han et al., 2011). This
platform is unique in that the np matrix facilitates the
generation of NO from encapsulated sodium nitrite through
a dinitrogen trioxide intermediate, as the rich disulﬁde
bonding network allows for long-range proton and electron
transfer/movement. As opposed to organic nitrates, the most
commonly used NO donor in clinical practice, there is no
potential for decreased efﬁcacy with prolonged and contin-
uous use, what is known as ‘nitrite tolerance,’ which results
from the prerequisite host reduction in the administered nitrate
to active NO (Bennett et al., 1994; Gori and Parker, 2002).
We have previously shown that NO-nps signiﬁcantly
increase the healing of methicillin-resistant Staphylococcus
aureus-infected wounds in a murine excisional injury model
(Martinez et al., 2009). NO-np also accelerated wound
healing in non-obese, diabetic, severe combined immunode-
ﬁciency mice, with signiﬁcantly decreased neutrophil and
increased macrophage inﬁltration noted in the NO-np-treated
wound beds as compared with another topical NO-donating
platform, diethylenetriamine (Blecher et al., 2012). Given the
antimicrobial and immunological properties of NO, we
investigated whether NO-np has antimicrobial activity against
Propionibacterium acnes and modiﬁes the inﬂammatory
cascade associated with the evolution of acne lesions.
RESULTS
Characterization of nps, detection of NO release, and tissue
penetration
NO-nps were formed using a previously described protocol
(Friedman et al., 2008). In brief, the highly anhydrous interior
of the nps facilitates the formation of N2O3 from nitrite and
protons. N2O3 is both the source of NO and is a potent
S-nitrosating agent that likely contributes to the biological
efﬁcacy of NO-np.
Using scanning electron microscopy, NO-np aggregates
were found to average ~ 127 nm in diameter (Figure 1a). We
have previously shown by transmission electron microscopy
that individual particles measure ~ 10 nm in diameter
(Friedman et al., 2008). Using dynamic light scattering, NO-
np revealed an average hydrodynamic diameter of 216.9 nm
based on 40 acquisition attempts (Figure 1b). The SD was
14.2 nm (3.3%), proving that NO-nps are homogenous in
size. As NO-nps swell with moisture, the average diameter is
likely an overestimate as compared with the scanning
electron microscopy. NO release from the NO-np has been
previously reported using both amperometric detection and
ozone chemiluminescence (Friedman et al., 2008; Cabrales
et al., 2010).
Antimicrobial activity of NO-np
NO generated from the NO-np has demonstrated antimicro-
bial activity against various Gram-positive and -negative
pathogens, including Staphylococcus aureus (Martinez et al.,
2009) and Pseudomonas aeruginosa (Friedman et al., 2011),
and therefore we sought to evaluate the impact on P. acnes.
P. acnes strains were incubated with various concentrations
of NO-np and np (0.625, 1.25, 2.5, or 5 mgml− 1) for 24 hours
(Figure 2a). For all isolates tested, all concentrations of NO-np
signiﬁcantly inhibited bacterial growth compared with con-
trols in a dose-dependent manner for up to 24 hours.
Concentrations over 2.5 mgml− 1 completely inhibited
growth over 24 hours, whereas 1.25 and 2.5 mgml−1
signiﬁcantly inhibited growth after 24 hours of co-incubation,
respectively (Po0.0001), as compared with all controls, as
well as 0.625mgml− 1 NO-np. Statistical signiﬁcance was not
met when comparing the two treatment groups (P=0.07). To
demonstrate the bactericidal activity against P. acnes, bacteria
were incubated with varying doses of NO-np, as well as np
control alone for 4 hours. Subsequently, the bacteria were
plated and the viability was determined by a colony-forming
unit assay. The NO-nps were effective at signiﬁcantly killing
P. acnes, resulting in only 8.9 and 4.6% survival for the two
concentrations illustrated (Figure 2b). Interestingly, the 2.5
and 5mgml− 1 np control had a modest, albeit a signiﬁcant
effect, compared with untreated cells, likely owing to the
physical presence of the nps that probably imparted a steric
effect, interfering with cell–cell interactions, noted in previous
investigations (Friedman et al., 2011).
NO-nps inhibit P. acnes–stimulated inﬂammatory cytokines
Given the importance of the inﬂammatory response in the
pathophysiology of acne, we evaluated NO’s ability to inhibit
inﬂammatory cytokine production from a P. acnes–chal-
lenged human keratinocyte cell line, HaCaT, and peripheral
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Figure 1. Nanoparticles (nps) characterization. (a) Scanning electron
microscopy revealed distinct spherical nps with irregular surface structure
indicative of the porous matrix lattice (bar = 100 nm). (b) Using dynamic light
scattering (DLS), nitric oxide–releasing np (NO-np) revealed an average
hydrodynamic radius of 108.47 nm based on 40 acquisition attempts. The SD
was 14.2 nm (3.3%), proving that NO-nps are homogenous in size.
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blood mononuclear cells (PBMCs). Previous studies showed
that P. acnes induces the inﬂammatory cytokines IL-1, IL-8,
and IL-12 in human monocytes and IL-6 in human
keratinocytes (Friedman et al., 2013; Qin et al., 2014). At
the same concentrations tested in the antimicrobial assays,
NO-np signiﬁcantly reduced P. acnes–stimulated human
monocyte (PBMC) expression of IL-1 β (52.0% reduction)
and tumor necrosis factor-α (TNF-α) (91.3% reduction) at the
highest dose tested (Figure 3a and b). Control np had no
inhibitory effect on IL-1β secretion at all concentrations tested
(S2). NO-np signiﬁcantly inhibited P. acnes–stimulated
PMBCs and HaCaT IL-6 and IL-8 secretion in a dose-
dependent manner as compared with controls (Figure 3c–f).
For IL-6 and IL-8 secretion, respectively, a statistically
signiﬁcant difference was noted when comparing control
with 2.5 mgml−1 (33.4 and 54.84% reduction) and 5mg-
ml− 1 (54.8 and 88.47% reduction) for the PBMC group and
with all treatment groups with the HaCaT cells (15.1, 51.5,
and 65.0%, and 48.31, 90.76, and 98.93, respectively).
With the recent attention paid to IL-1β as the initial
subclinical stimulus for follicular hyperkeratinization, its
place in and importance of the NLRP3 (NLR, nucleotide
oligomerization domain-like receptor) inﬂammasome with
respect to P. acnes induction of the host defense (Qin et al.,
2014), we sought to determine whether the aforementioned
anti-inﬂammatory effects resulted from NO-np’s impact on
this multi-protein complex. To evaluate whether NO-np
reduction of IL-1β, IL-6, and TNF-α secretion was mediated
speciﬁcally through NO activity on NLRP1 and/or NLRP3,
small interfering RNAs (siRNAs) were used to silence speciﬁc
gene expression as previously described (Qin et al., 2014).
Transfection of monocytes with speciﬁc siRNA targeting
NLRP3 resulted in a signiﬁcant reduction in IL-1 β expression
(93.8%, Po0.01) (Figure 4a), as compared with stimulated
controls, respectively. A nonspeciﬁc control siRNA had no
effect in all cases. Although siNLRP3 transfection of PBMCs
resulted in a 93.8% reduction in IL-1β secretion, NO-np
treatment provided further statistically signiﬁcant reduction
(499%) as compared with stimulated siNLRP3 control. In
congruence with past results, siNLRP1 transfection of PBMCs
resulted in a minimal reduction in P. acnes–induced IL-1 β
secretion, whereas a 55.27% reduction in IL-1 β expression
following NO-np treatment compared with untreated was
noted. Interestingly, knockout of NLRP3 did not inﬂuence P.
acnes–stimulated secretion of IL-6, IL-8, or TNF-α from PMBCs,
and NO-np treatment yielded similar reductions in cytokine
secretion as noted above (S1a-c). However, knockdown of
NLRP1 had a signiﬁcant effect in NO-np inhibition of IL-6
secretion from PBMCs as compared with NLRP3 knockdown.
NO-nps inhibit P. acnes–induced caspase-1 and IL-1β, but not
NLRP3, gene expression
Given the additional reduction in IL-1β secretion from
siNLRP3-transfected PBMCs beyond the effects of knockdown
alone, we sought to evaluate NO-np activity on gene
expression of key inﬂammasome components. IL-1β and
caspase-1 mRNA levels were signiﬁcantly reduced in PBMCs
exposed to P. acnes and treated with NO-np as compared with
controls (87.1 and 80.0% reduction, respectively; Figure 4a
and b), with an associated decrease in caspase-1 production
and activity (Figure 5a and b). NO-np treatment had minimal
effect on both NLRP3 and apoptosis-associated speck-like
protein containing a CARD mRNA expression as compared
with controls (Figure 4d and e). NO-np alone did cause a slight
but a signiﬁcant increase in IL-1β mRNA expression.
NO-nps are non-toxic
All concentrations of NO-np tested had minimal toxicity to
keratinocytes and PBMCs using the MTT (3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrasodium bromide tetrazolium) assay
(P=0.31 and 0.13, respectively, as compared with control)
(Figure 6a and b), which was further substantiated using
embryonic zebra ﬁsh assays (Figure 6c). The embryonic
zebraﬁsh assay was used to assess the toxicological impact of
NO-np in an in vivo vertebrate model system. Embryos
exposed to NO-nps did not exhibit differences in rates of
malformations or mortality at any concentration tested
compared with controls. Any differences in morphology,
mortality, development, larval morphology, or behavioral
endpoints between treatment and control were attributed
to laboratory background. Therefore, our data suggest that
NO-nps can inhibit P. acnes–induced cytokine production in
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Figure 2. Antimicrobial effects of nitric oxide–releasing nanoparticles
(NO-nps). (a) Susceptibility of P. acnes isolates to varying concentrations of
empty nps and NO-np (0.625, 1.25, 2.5, and 5mgml−1) was investigated
by real-time Bioscreen analysis and (b) the colony-forming unit assay
determination (mean colony-forming unit per ml). Experiments were repeated
in triplicate and performed at least thrice on separate days. Asterisks denote
P-value signiﬁcance calculated by unpaired two-tailed t-test analysis.
*Po0.05; **Po0.01.
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human keratinocytes and PBMCs, and this is not a conse-
quence of the release of cytokines at cell death.
DISCUSSION
In this work, we demonstrated that the NO-nps effectively
decreased P. acnes viability and inhibited IL-1β, TNF-α, IL-8,
and IL-6 secretion from P. acnes–stimulated PMBCs, and IL-8
and IL-6 from keratinocytes, while neither having in-vitro nor
in-vivo cytotoxicity. Although NO-np was found to have an
impact on components of the NLRP3 inﬂammasome pathway,
its anti-inﬂammatory effects were not speciﬁc to NLRP3 and
NLRP3 knockout did not impair NO-np’s anti-inﬂammatory
properties.
Nearly every member of the skin cell population expresses
NO synthase and is thereby able to produce NO to
accomplish key physiologic processes. NO’s role in skin host
defense is concentration dependent and is imparted in a
bimodal manner. At low concentrations it stimulates the
immune system by enhancing immune cell activity, cytokine
production, expression of adhesion factors, and extracellular
matrix constituent synthesis. High output of endogenous NO
is achieved through the stimulation of pathogen recognition
receptors that promote induced NO synthase transcription
and subsequent L-arginine-dependent NO release (Grifﬁth
and Stuehr, 1995). This calcium-independent enzymatic
pathway along with the nonenzymatic reduction in naturally
occurring nitrosothiols and nitrate (NO3
−) are the two key
methods of endogenous NO synthesis pertinent to microbial
eradication (Weller, 2009). The coupling of NO and O2
−
produces potentially toxic reactive nitrogen species, such as
the peroxynitrite anion (ONOO−), and induces increased O2
−
production (Fang, 2011). Reactive nitrogen species can
interfere with normal protein interactions as protein thiols
become nitrosated (Han et al., 2011). Collectively, these
molecules adversely affect microbial viability by traversing
cellular membranes, interrupting DNA replication, instigating
lipid peroxidation, and inactivating metalloproteinases
essential for microbial metabolism (Wink and Mitchell, 1998).
P. acnes, which resides in pilosebaceous follicles in both
acne and non-acne subjects, elicits inﬂammatory responses
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Figure 3. Nitric oxide–releasing nanoparticle (NO-np) signiﬁcantly inhibits P. acnes–induced pro-inﬂammatory cytokines in peripheral blood mononuclear
cell (PMBC) and keratinocytes. P. acnes–stimulated PBMC expression of IL-1β (a), tumor necrosis factor-α (TNF-α) (b), IL-6 (c), and IL-8 (e), and HaCaT cell
expression of IL-6 (d) and IL-8 (f) with and without various concentrations of NO-np. NO-np at 2.5 mgml−1 was used as a control. IL-1β and TNF-α were
undetectable in the HaCaT supernatant via ELISA assay (data not shown). The data are presented as the mean of triplicate wells± SD and are representative of
three individual experiments. *Po0.05; **Po0.01.
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essential for the pathogenesis and clinical phenotype of acne
vulgaris (Bellew et al., 2011). P. acnes was found to be highly
sensitive to NO derived from the NO-np. Perhaps the most
signiﬁcant aspect to be considered of NO’s microbicidal
activity is the lack of demonstrated resistance to date. This is
thought to be a direct result of the aforementioned multiple
mechanisms of NO’s action—to overcome would require the
simultaneous development of distinct resistance mutations.
Some minor compensatory mechanisms against the actions of
NO have been elucidated; however, no protection against the
high concentrations of NO released by donating materials is
evident. Isolates of S. aureus, Staphylococcus epidermidis,
Escherichia coli O157:H7, and P. aeruginosa that survived
exposure to high NO concentrations showed no increase in
minimum inhibitory concentration levels afterward (Privett
et al., 2012). Given the ongoing concern regarding antibiotic
resistance in P. acnes, NO-np represents a much needed
multi-mechanistic antimicrobial approach (Eady, 1998; Ross
et al., 2003).
Although P. acnes is implicated in the pathophysiology of
acne vulgaris, it serves more as a pro-inﬂammatory stimulus
rather than a pathogenic organism, and therefore muting this
response is central to clinical treatment. We found that
NO-np inhibited IL-8 and IL-6 production from P. acnes–
stimulated PBMCs and keratinocytes in a dose-dependent
manner. IL-8 is a CXC chemokine that serves as a potent
chemoattractant for neutrophils, a predominant cell type in
acne-related lesions. IL-8 gene expression has been shown to
be signiﬁcantly elevated in biopsy specimens of acne lesions
(Trivedi et al., 2006). IL-6 is a pleiotropic cytokine having an
important role in acute and chronic inﬂammation. IL-6 has
also been shown to contribute to persistent neutrophil
trafﬁcking in wounds, resulting in delayed wound healing in
the setting of sustained stress. Interestingly, we found that
NLRP1 may have a role in NO-np downregulation of P.
acnes–induced IL-6 expression, as compared with NLRP3,
warranting further investigation.
NO-np had a profound effect on the secretion of TNF-α
from PBMCs. TNF-α is central to stimulating the acute phase
reaction of the immune response. Implicated in multiple
dermatologic diseases including acne, several studies have
highlighted that single-nucleotide polymorphisms of the
TNF-α gene (such as the −308 G/A polymorphism) are
associated with an increased risk to develop chronic inﬂamma-
tory disease (Yang et al., 2014). NO-np signiﬁcantly inhibited
PBMC induction of TNF-α triggered by P. acnes, almost
completely at the highest concentration tested (5mgml−1).
*
*
*
*
*
*
350
300
250
200
150
100
50
0
6
5
4
3
2
1Ca
sp
as
e-
 1
 re
la
tiv
e 
m
R
N
A 
ex
pr
es
sio
n
N
LR
P3
 re
la
tiv
e 
m
RN
A 
e
xp
re
ss
io
n
AS
C 
re
la
tiv
e 
m
RN
A
e
xp
re
ss
io
n
0
IL
-1
β 
re
la
tiv
e 
m
R
N
A 
e
xp
re
ss
io
n
400
**
**
**
*
*
IL
-1
β (
pg
 m
l–1
)
1,200
1,000
800
600
400
150
100
50
0
P. acnes
NO-np (mg ml–1)
NO-np (mg ml–1)
NO-np (mg ml–1)NO-np (mg ml–1)
NO-np (mg ml–1)
– –
––
52.51.25
P. acnes
Cells alone Scramble siRNA siNLRP3 siNLRP1
– + +
+ +– –
– – + +
+ +– –
–– + +
+ +– –
–– + +
+ +– –
–
+
++++
– –
––
52.51.25
P. acnes
+
++++
– –
––
52.51.25
P. acnes
+
++++
– –
––
52.51.25
P. acnes
+
++++
2
1.5
1
0.5
0
3
2.5
2
1.5
1
0.5
0
Figure 4. Nitric oxide–releasing nanoparticle (NO-np) inhibits peripheral blood mononuclear cell (PBMC) IL-1β secretion by directly downregulating IL-1β
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PCR (b–e). Data are shown as the mean of triplicate wells± SD and are representative of three individual experiments. *Po0.05; **Po0.01.
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NO is known to modulate several innate immune path-
ways, enhancing the host’s own immune response; for
example, NO is involved in lymphocyte activation and
proliferation, and numerous cytokine pathways, including
TNF-α, transforming growth factor-β, p56, IL-6, and NF-κB
(Fang, 1997). However, although an important recruiter of host
defense against invading pathogens, NO’s immunoregulatory
function is clearly multi-faceted—NO can function as an anti-
inﬂammatory agent when appropriate, as demonstrated in this
study. For example, investigators have shown that NO inhibits
key members of the inﬂammatory cascade, such as NF-κB and
STAT-1 in keratinocytes (Giustizieri et al., 2002), and
downregulates neutrophil aggregation, secretion, and
diapedesis (Dal Secco et al., 2003). We too demonstrated
that NO-np inhibits secretion of various pro-inﬂammatory
cytokines from different cell types stimulated with P. acnes.
In light of the recent data highlighting the role of caspase-
dependent IL-1β generation through the NLRP3 inﬂamma-
some pathway in the pathophysiology of acne vulgaris, (Qin
et al., 2014), we showed that NO-np inhibits P. acnes–
stimulated PBMC IL-1β and caspase-1 gene expression, likely
explaining the additional reduction in IL-1β secretion from P.
acnes–stimulated siNLRP3-transfected monocytes treated
with NO-np. The NLRP3 inﬂammasome is a multi-protein
complex that triggers the maturation of the pro-inﬂammatory
cytokines IL-1β and IL-18 (Hernandez-Cuellar et al., 2012).
This complex can be activated by pathogen-associated
molecular patterns or endogenous danger-associated molecu-
lar patterns generated in the setting of cellular injury or tissue
damage (Dostert et al., 2008; Schroder and Tschopp, 2010;
Qin et al., 2014). Interestingly, one of NO’s roles may be as a
negative regulator of inﬂammasome activity. It was previously
shown that inﬂammasome activation was inversely correlated
to induced NO synthase expression, and that NO inhibited
IL-1β production and caspase-1 activation (Mao et al., 2013).
The mechanism by which NO is believed to inhibit the various
elements of the inﬂammasome is via S-nitrosylation of several
proteins involved in cellular regulation, ultimately impacting
their activity and function (Stamler et al., 2001). We
demonstrated that NO-np did not reduce the gene expression
of NLRP3; however, this ﬁnding does not provide insight into
NLRP3 activity or the degree of nitrosylation. We have
previously shown that the NO-nps are effective trans-nitrosat-
ing agents (Friedman et al., 2011), likely owing to the nps
forming a dinitrogen trioxide intermediate, capable of S-
nitrosation under aerobic and anaerobic conditions, which
therefore offers a mechanism for the observed activity.
Regardless of NLRP3 function, we demonstrated NLRP3-
independent anti-inﬂammatory effects in a NLRP3 knock-
down model, likely owing but not limited to NO-np’s direct
effect on caspase-1 and IL-1β gene expression. This ﬁnding
has far reaching implications in many disease states given the
broad role of both in all inﬂammasome pathways. Interest-
ingly, knockdown of NLRP3 did not impact NO-np suppres-
sion of P. acnes–stimulated monocyte-derived IL-6, IL-8, and
TNF-α, once again supporting NO’s multi-mechanistic anti-
inﬂammatory activity and highlighting NO’s target diversity.
Not surprisingly, we found that NO-np alone mildly
induces PBMC IL-1β expression in the absence of pathogen
stimulus, highlighting the duality of NO’s functions in
immune regulation. We and other investigators have shown
that at low concentrations, NO stimulates PMBC generation
of IL-6, but as NO levels increased using NO-donor
molecules both IL-6 expression and NF-κB activity decreased.
A greater degree of nitrosative stress increases the likelihood
of protein S-nitrosylation, in this case, of key NF-κB-related
proteins including IκB kinase b and p50, which was shown to
directly inhibit pro-inﬂammatory activity (Marshall et al.,
2004). This further supports any NO-releasing technology that
facilitates trans-nitrosylation. Therefore, the current theory is
that in the early stage of infection, lower, initial concentra-
tions of NO may accelerate the immune response by
stimulating the synthesis of proinﬂammatory cytokines,
whereas at a later stage, when NO concentrations have
peaked and cells are activated, it rather counteracts the
undesired development of inﬂammation.
Together, the presented and past data, demonstrating that
NO-nps have multi-mechanistic antimicrobial and anti-
inﬂammatory properties, suggest that NO-np can potentially
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Figure 5. Nitric oxide–releasing nanoparticle (NO-np) downregulates P.
acnes–induced caspase-1 protein expression and activity in peripheral blood
mononuclear cells (PBMCs). PBMCs were isolated from whole blood of
normal healthy donors. Transfected cells were plated into six-well cell culture
plates, cultured at 37 °C overnight, and co-cultured with or without
2.5 mgml− 1 control-np and 2.5 mgml− 1 NO-np for an hour. Cells were then
infected by P. acnes at a multiplicity of infection (MOI) 0.5 for 24 hours. Cells
were lysed and caspase-1 protein expression was measured with western blot
(a) and activity assay (b). (a) Western blotting using anti-caspase-1: cells alone
(lane 1); P. acnes (lane 2); control np (lane 3); NO-np (lane 4); P. acnes in the
presence of NO-np (lane 5); P. acnes in the presence of control np (lane 6). (b)
Caspase-1 activity assay: cells were normalized as a percentage of control
cells. NO-np signiﬁcantly decreases PBMC caspase-1 protein activity in the
presence of P. acnes compared with control-np. *Po0.05.
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target multiple pathophysiologic elements of acne vulgaris.
Importantly, in the face of rising of antimicrobial resistance in
the setting of prolonged antibiotic use, NO’s bactericidal and
static properties limit the risk of the emergence of resistant
species. Therefore, our ﬁndings suggest that the NO-np offers
a new approach to harness the therapeutic potential of NO,
and that this platform should be translated to the bedside.
MATERIALS AND METHODS
Production of NO-np
The production of the NO-np has been previously reported
(Friedman et al., 2008). Brieﬂy, the NO-nps are prepared using the
following sequence of steps: (1) hydrolyzing tetramethylorthosilicate:
stock of 5 ml of tetramethylorthosilicate, 600 μl of deioinized water,
and 560 μl of 2 mM hydrochloric acid are added to a small vial. The
contents of the vial are sonicated for ~ 20–30minutes, yielding a
clear solution that is then placed on ice. (2) Mixing the sol-gel
components: 1.49 g of sodium nitrite is dissolved in 4ml of PBS
buffer at pH 7.5 followed by sequential addition and mixing of 0.5 ml
of polyethylene glycol-200 and 500 μl of chitosan (1 mgml−1). The
resulting mixture is then vortexed thoroughly. Next, 2 ml of
previously hydrolyzed tetramethylorthosilicate is added to the
solution followed by vigorous vortexing until complete gelation. (3)
Lyophilizing the sol-gel: The resulting gelled material is then
lyophilized for 24–48 hours, which removes all volatile components.
(4) Ball milling the lyophilized sol-gel: following lyophilization, the
dry material is ball milled at 150 r.p.m. for 8 hours, resulting in a very
ﬁne white powder.
Nanoparticle imaging
For nanoparticle imaging, see Supplementary Methods online.
Dynamic light scattering
For dynamic light scattering, see Supplementary Methods online.
Nanoparticle skin penetration
Retired breeder male Sprague–Dawley rats (650 g, Charles River
Breeding Laboratories (Wilmington, MA)) were used in these studies.
All animal protocols were approved by the Animal Use Committee at
the Albert Einstein College of Medicine. Rats (n= 3) were ﬁrst
anesthetized via intraperitoneal injection of sodium pentobarbital
(35 mg kg−1; Abbott Laboratory, Chicago, IL). Four aliquots of 50 μl
of Alexa Fluor 594 nm–labeled NO-np (5 mgml−1) suspended in
coconut oil were applied to the four abdominal quadrants of the
abdomen. Coconut oil alone was used as a control (n= 1). After
10minutes, quadrants were cleaned with alcohol wipes and 4-mm
punch biopsies were taken from each application site. Specimens
were subjected to frozen sectioning and vertical sections (4-mm-
thick) were ﬁxed to glass slides. Images were captured with a
confocal microscope (PerkinElmer, Waltham, MA) with a × 10, 1.4
numericl aperture objective and a digital camera (Orca ER,
Hamamatsu, Japan).
Colony-forming unit assay and bioscreen analysis
P. acnes strain ATCC 6919 was obtained from American Type
Culture Collections and isolates grown in the miniMACS anaerobic
workstation (Don Whitley Scientiﬁc, West Yorkshire, UK). Brieﬂy,
Brucella agar plates supplemented with blood, hemin, and vitamin K
(Remel Fisher Scientiﬁc, Lenexa, KS) were streaked with P. acnes
overnight and single colonies isolated.The cultures were grown in an
anaerobic chamber for 4–5 days. A spectrophotometer OD600 was
used to determine the bacterial log phase.
Various concentrations of control and NO-nps (0.625, 1.25, 2.5,
and 5mgml− 1) were incubated with 3.75× 105 bacteria in a ﬁnal
volume of 30 ml at 37 °C for 4 hours. After incubation, 10-fold
dilutions were prepared and incubated for 4 days at 37 °C under
anaerobic conditions. Individual colonies were counted and the
number of colony-forming unit was tabulated.
For growth kinetics, reinforced Clostridium medium was inocu-
lated with a fresh colony grown on the Brucella agar plates and
suspended in 1ml of medium. A suspension of 100 μl of bacteria was
transferred to a 200-well plate with 100 μl of reinforced Clostridium
medium per well containing NO-np or np (0.625, 1.25, 2.5, and
5mgml−1). Bacteria and nps were incubated for 24 hours at 37 °C.
Controls included wells containing bacteria with reinforced Clos-
tridium medium alone. Growth was assessed at OD600 every 30
minutes using a microplate reader (Bioscreen C, Growth Curves USA,
Piscataway, NJ).
P. acnes culture and cell stimulation
PBMCs were stimulated by P. acnes strain 6919 at multiplicity of
infection (MOI) 0.5, whereas HaCaT keratinocytes were infected by
P. acnes at MOI 20 (Qin et al., 2014). We used live P. acnes as
opposed to sonicated-killed preparations of P. acnes due to the
pathophysiological relevance of our model and consistency on the
observed responses.
120
* *
100
80
60
40
20
0
100
%
 m
or
ta
lity
 a
t 1
20
 h
pf 0 p.p.m.
250 p.p.m.
80
60
40
20
0
0
0.
01
6
0.
08 0.
4
Concentration (p.p.m.)
2 10 50 25
0
%
 M
et
ab
ol
ic 
ac
tiv
ity
– 1.25 2.5 5.0
120
100
80
60
40
20
0
%
 M
et
ab
ol
ic 
ac
tiv
ity
– 1.25 2.5 5.0No-np
mg/ml
Figure 6. Nitric oxide–releasing nanoparticles (NO-nps) are non-toxic. NO-
nps at various concentrations (1.25, 2.5, and 5mgml−1, respectively) were
incubated with HaCaT cells (a) or peripheral blood mononuclear cells
(PBMCs) (b). Cells were collected and evaluated for viability using the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrasodium bromide tetrazolium)
assay. (c) Representative images of zebraﬁsh embryos at 120 hpf: control (top)
and exposed to NO-np (bottom). No signiﬁcant differences were observed in
larval morphology or behavioral endpoints (P40.05 for each endpoint
evaluated, Fisher’s exact test). Error bars denote SEM.
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Isolation of PBMCs, HaCaT cell culture, and cytokine ELISA
PBMCs were isolated from whole blood of normal healthy donors as
approved by the Institutional Review Board at UCLA using Ficoll-
Paque gradients (GE Healthcare, Piscataway, NJ) and plated onto
24-well tissue culture plates (5× 106 per well) in RPMI 1640 media
containing 10% fetal bovine serum (HyClone, South Logan, UT).
Cells were co-cultured 1 hour with 0, 1.25, 2.5, and 5mgml− 1 of
NO-nps, respectively. Then, cells were infected by P. acnes at MOI
0.5 for 24 hours at 37 °C.
HaCaT cells, an immortalized human keratinocyte cell line, plated
into six-well tissue culture plates (5× 105 per well) and cultured at
37 °C with 5% CO2 in DMEM (Gibco11995-060, Invitrogen,
Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine
serum (HyClone) and 1% penicillin/streptomycin (Gibco 15140-122,
Invitrogen) for 18 hours. HaCat cells retain their ability to differ-
entiate, to express Toll-like receptors involved in pathogen recogni-
tion, and to produce a number of cytokines in response to bacterial
stimulation in a similar manner to primary human keratinocytes
(Grange et al., 2009). HaCaT cells were treated 1 hour with the
different doses of NO-nps as above. Then, cells were infected by P.
acnes at MOI 20 for 24 hours at 37 °C.
IL-6, IL-8, IL-1β, and TNFα levels in culture supernatants were
measured by ELISA assay following the manufacturer’s recommenda-
tions (R&D ELISA Development System, Minneapolis, MN). Samples
were assayed in triplicates. Results are expressed as mean± SD of at
least three independent experiments, with PBMCs obtained from
three independent donors.
RNA isolation, cDNA synthesis, and real-time PCR
For RNA isolation, cDNA synthesis, and real-time PCR, see
Supplementary Methods online.
siRNA transfection
siRNA transfection into PBMCs was accomplished by using the Amaxa
Nucleofector system and the Nucleofector Kit (Lonza, Allendale, NJ)
according to the manufacturer’s recommendations, with program
U-001 for high viability. siRNA constructs (scramble, siNLRP3, and
siNLRP1) were used at 1 μg per transfection. Transfection efﬁciency of
expression constructs was assessed using the pMAX-GFP construct
and it yielded an average of 70% transfection rate (Lonza, Allendale,
NJ). Transfected cells were plated into six-well cell culture plates and
cultured at 37 °C for overnight. Transfected cells were co-cultured with
NO-np 2.5mgml−1 for an hour and then infected by P. acnes at
MOI 0.5.
Western blot analysis
Detection of caspase-1 was performed by western blot analysis.
Isolated PBMCs were treated with 2.5 mgml− 1 NO-np or control np
for an hour. Cells were then infected by P. acnes with MOI 0.5. After
24 hours, cells were collected and lysed in 100 μl of lysis buffer
(M-PER Mammalian Protein Extraction Reagents, Thermo Scientiﬁc,
Waltham, MA) with protease inhibitors. Protein levels were normal-
ized with the Bradford assay. Protein proﬁles were separated by
electrophoresis in BIO-RAD (Hercules, CA) mini PROTEAN TGX
polyacrylamide precast gels and transferred onto 0.45 μm Millipore
(Billerica, MA) Immobilon P-transfer membranes, and caspase-1 was
detected by caspase-1 monoclonal antibody (D7F10, Cell Signaling,
Danvers, MA). The bands from western blotting were visualized by
using VersaDOC MP5000 (BIO-RAD).
Activity assay
Isolated PBMCs were treated with 2.5 mgml− 1 NO-np or control np
for an hour. Cells were then infected by P. acnes with MOI 0.5. After
24 hours, cells were collected and lysed with 100 μl of cold lysis
buffer. Caspase-1 protein activity was then measured using the
Caspase-1 Colorimetric Assay (R&D Systems, Minneapolis, MN) as
per the manufacturer’s instructions and the activity was determined
via percentage of the control (cells alone). After 16 hours of
incubation at 37 °C, activity was read using BioTek Synergy 2
(Winooski, VT) plate reader using a wavelength of 405 nm.
MTT toxicity assay
The MTT assay (Sigma Aldrich) was performed as previously
described (Friedman et al., 2013) (see Supplementary Methods
online for complete methods).
Statistical analysis
GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA) was used for
statistical analyses. P-values were determined by analysis of variance
and adjusted by the use of Bonferroni correction. P-values of o0.05
were considered signiﬁcant
In vivo toxicity assay
Zebraﬁsh embryos (Danio rerio, wild type, 5D-Tropical strain) were
obtained from Sinnhuber Aquatic Research Laboratory, Oregon State
University, and exposures and evaluations were conducted according
to Truong et al. (2011). Exposures were conducted over 5 days of
development. All organ systems begin functioning during this time
period and all of the molecular signaling pathways are active and
necessary for normal development to occur. At 120 hpf, behavioral
endpoints (motility and tactile response) and larval morphology (body
axis, eye, snout, jaw, otic vesicle, notochord, heart, brain, somite, ﬁn,
yolk sac, trunk, circulation, pigment, and swim bladder) were
evaluated in vivo and scored in a binary manner (present or
absent). Untreated control and exposed groups were compared
using Fisher’s exact test for each endpoint and P-value o0.05 for
signiﬁcance.
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